"*" indicates required fields
;)
With renewed growth and our patients at the forefront of all we do, Kaléo is committed to an active pipeline across a range of therapeutic areas. We are dedicated to developing innovative products and solutions with patient-centered designs that offer the reliability and flexibility to protect and improve the lives of patients.
An industry leader in Human Factors Engineering and drug-device combination product development and manufacturing, we will continue with our forward-thinking approach when developing products and solutions that will meet the growing unmet needs of the patient and the pharmaceutical industry.
This gas powered auto-injector is a compact, portable device that is easy-to-use. The Aerio Platform uses proprietary gas-powered technology that enables delivery of larger volume and higher viscosity formulations and controls injection flow rates. The Aerio auto-injector is available in three different versions: single container, dual container, and dual chamber.
By clicking proceed, you will leave www.kaleo.com, the kaleo, Inc. corporate page. You will proceed to the AUVI-Q® (epinephrine injection, USP) product page, intended for residents of the United States of America.
Proceed
By clicking proceed, you will leave www.kaleo.com, the kaleo, Inc. corporate page. You will proceed to the ALLERJECT® (epinephrine injection, USP) product page, intended for residents of Canada.
Proceed
By clicking proceed, you will leave www.kaleo.com, the kaleo, Inc. corporate page. You will proceed to the Naloxone Auto-Injector 10 mg (NALOXONE HYDROCHLORIDE INJECTION, USP) product page, intended for military personnel and chemical incident responders.
Proceed